Breaking News, Promotions & Moves

Avantor Names R. Brent Jones Chief Financial Officer

Jones has served as chief financial officer for several public and private life sciences companies.

Avantor Performance Materials, Inc., a global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, appointed R. Brent Jones executive vice president and chief financial officer, effective August 7, 2023. Jones will replace Thomas Szlosek, who will begin a new role outside the life sciences industry.

Over a nearly 30-year career, Jones has served as chief financial officer for several public and private life sciences companies and, previously, as a senior investment banker. He is currently executive vice president, chief financial officer and chief operating officer at LifeScan Global Corp., where he is responsible for all aspects of LifeScan’s global finance and operations functions.

As chief financial officer and member of Avantor’s executive leadership team, Jones will lead Avantor’s global finance organization and financial activities including accounting and controllership, financial planning and analysis, tax, investor relations, internal audit, and treasury.

“Brent distinguished himself in our search as an innovative thinker and dynamic operator who will be an exceptional partner to our businesses and executive leadership team as we advance our growth plan,” said Michael Stubblefield, President, and CEO. “Brent has a strong track record of disciplined execution and transformation, honed over many years of leading and advising finance organizations in the life sciences industry. I look forward to welcoming him to Avantor and working together to ensure the continued execution of our strategy.”

“Avantor has an attractive market position, powerful fundamental drivers, and a solid platform for long-term growth,” said Jones. “I am excited to join Avantor during this important period in the company’s trajectory and will be partnering closely with the leadership team and finance organization to harness Avantor’s unique value proposition, execute its growth strategy, and create shareholder value.”

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters